ARCHIVES

In Brief: Henney Names Acting Director Of DRCCA: House Bill Would Slash Deeply Into Research Using Animals

This article is from The Cancer Letter archive.

Vol. 07 No. 37 | September 11, 1981

Download PDF Visit The Full Archive

Related Articles

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

Congress Agrees On $1.989 Bil. FY92 NCI Budget, But Most Of Increase Not Available Till 1993

November 8, 1991